Open access policy:
Zagazig journal of pharmaceutical sciences (ZJPS) is an open access journal making research freely available to the public to support a greater global exchange of knowledge. All articles published in ZJPS are made available under the Creative Commons CC BY-NC-ND license (https://creativecommons.org/licenses/), which enables reusers to copy and distribute the articles in any medium or format in unadapted form only, for noncommercial purposes only and only so long as attribution is given to the authors. Authors retain the copyrights. This policy is in accordance with the Budapest Open Access Initiative (https://www.budapestopenaccessinitiative.org/boai-10-recommendations).
Copyright and Publication Rights
Authors retain the copyrights.
Authors have the right to:
Authors can use their articles for non-commercial purposes such as:
Authorship of the Paper:
Authorship is limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. It is recommended to declare the contribution of each author in the manuscript.
Order of authors and their affiliations including that of the corresponding author should be correct at submission.
Adding and/or deleting authors after acceptance of a manuscript is not permitted.
Compliance with Ethical Standards
Authors should include information regarding sources of funding, potential conflicts of interest and acknowledgement of sources.
Studies on patients, volunteers, or animals require ethics committee approval and informed consent form patients or volunteers, which should be cited in the paper.
Conflicts of interest
When a participant in the peer review and publication process - author, reviewer, and editor has ties to activities that could inappropriately influence his or her judgment. Financial relationships with industry are usually considered to be the most important conflicts of interest. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.
Authors are responsible for recognizing and disclosing financial and other conflicts of interest. They should acknowledge in the manuscript all financial support for the work and other financial or personal connections to the work.
Originality and plagiarism:
All new submissions to ZJPS are automatically screened using Crossref Similarity Check (powered by iThenticate) to screen all new manuscripts for plagiarism within the editorial system. Editors may choose to run a similarity report at any other stage during the peer review process. Authors and researchers can also use iThenticate to screen their work before submission by visiting http://www.ithenticate.com/.
Multiple, redundant, or concurrent publications:
The manuscript should not be submitted to more than one journal for simultaneous consideration.
An author should not publish manuscripts describing the same research in more than one journal.
Prior publication in the form of an abstract or publication as an academic thesis is allowed.
Data access and retention:
Authors may be asked to provide the raw data in connection with a paper for editorial review.
Fundamental errors:
Authors should correct mistakes once they discover a significant error in their published article.
Authors should contact the journal and explain in what sense the error is impacting the article.
Based on the nature of the error, the decision may be a correction or retraction.
Article withdrawal and retraction:
In case of misbehavior, the Journal contacts the author(s) by email and gives an opportunity to address the issue. Depending on the situation, the decision may be one of the followings:
- An erratum/correction may be placed with the article
- An expression of concern may be placed with the article
- Or in severe cases retraction of the article may occur. The reason will be given in the published erratum, expression of concern, or retraction note.
Editors of ZJPS follows the ICMJE's Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. (see: https://www.icmje.org/recommendations/browse/about-the-recommendations/purpose-of-the-recommendations.html).
Our Editors follow guidelines and best practices published by professional organizations, including Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from ICMJE (www.icmje.org/icmje-recommendations.pdf) and Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice).
Our Editors are familiar with the Committee on Publication Ethics (COPE) “Code of Conduct and Best Pracice Guidelines for Journal Editors” (see: https://publicationethics.org/about/our-organisation).
Editorial Freedom
Zagazig Journal of Pharmaceutical Sciences follows the World Association of Medical Ethics (WAME) (available at: https://wame.org/editorial-independence). Editorial freedom is defined as editors holding full responsibility for editorial decisions on individual manuscripts. Editors base their editorial decisions on the transparency, validity, and quality of all manuscripts, and our Editors are free to express concerns but responsible views without fear of forfeit. Our Editors are supported by the Editorial board who assists the Editor with editorial policy.
Confidentiality
All manuscripts submitted to ZJPS are secure. The Journal’s Editorial Board, and all editorial and publication staff keep all information about submitted manuscripts confidential, sharing it only with those involved in the peer review and publication processes.
Peer review and timeliness
Our Editors select expert reviewers within the topic of each submitted manuscript from the journal database or suggested by JANE or Publons (WOS). Editors ensure that reviewer comments are properly assessed and interpreted with declared conflicts of interest. Editors will do their best to ensure the timely processing of manuscripts according to the peer review policy (see: https://zjps.journals.ekb.eg/journal/process). Manuscripts submitted by a member of a journal’s editorial team are independently peer-reviewed. In this case, the Editor will have no role in the peer review process or publication decision for his own article.
Competing interests
The Journal’s Editors give editorial decisions based on the relevance of a manuscript to the journal and on the manuscript’s originality, quality, and transparency without being influenced by commercial benefits or conflicts of Interest.
Ethical approval
Our Editors can reject manuscripts that do not comply with the following requirements:
Research work involving human participants, human material, or human data should be performed in accordance with the Declaration of Helsinki (See: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/).
Informed consent and ethics committee/IRB approval: A paper describing experimental work in humans must: (1) indicate that informed consent has been obtained from patients where appropriate, (2) include a statement that the responsible ethics committee (e.g: Institutional Review Board, Faculty of Medicine, Zagazig University) has given approval. Do not use patients’ names, initials or hospital numbers, especially in illustrative material.
All animal experiments should comply with the ARRIVE guidelines
(see: https://arriveguidelines.org/), and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments
(see: https://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm).
Dealing with possible misconduct
Our Editors will reject papers with raised concerns about possible misconduct and will be ethically obliged to pursue alleged cases. Editors will seek a response from authors suspected of misconduct. If they are not satisfied with the response, they will raise their concerns to the relevant employers, or institution, or appropriate body.
Acknowledgement: Proper acknowledgment of the work of others must always be given and All sources of financial support should be disclosed.